Status:
ENROLLING_BY_INVITATION
Optimization of Exhaled Biomarker Collection and Analysis
Lead Sponsor:
Indiana University
Conditions:
Respiratory Disease
Healthy
Eligibility:
All Genders
4-110 years
Phase:
NA
Brief Summary
This is an exploratory study designed to optimize, standardize, and validate novel breath biomarkers; there are no objective endpoints. The goal of this study is to generate pilot data to be used to g...
Detailed Description
Exhaled breath has three fractions - gaseous breath, volatile breath, and breath condensate. Biomarkers have been identified in each of these fractions and non-invasive collection methods have been de...
Eligibility Criteria
Inclusion
- Study sample will consist of individuals aged 4-110 with a diagnosis of acute or chronic respiratory disorders, or metabolic or systemic conditions involving diffuse inflammation, or normal subjects with no pulmonary disease.
Exclusion
- Subjects that are unable or unwilling to cooperate with specimen collection.
Key Trial Info
Start Date :
February 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05322785
Start Date
February 2 2020
End Date
January 31 2030
Last Update
March 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Indiana University School of Medicine - Wells Center for Pediatric Research
Indianapolis, Indiana, United States, 46202